Abstract
Longer remissions and better overall survival rates can be achieved with the introduction of new, effective treatments and targeted therapies in the past 1-2 decades, however, the incidence of side effects is also increasing parallelly. Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially debilitating side effect due to peripheral somatic or autonomic nerve dysfunction. CIPN becomes increasingly important, as it affects patients' quality of life, and it is very often a dose limiting factor with the potential for reduced treatment efficacy. The pathomechanism, diagnosis, prevention and treatment possibilities are described in this review with special attention to the different groups of drugs.
| Original language | Hungarian |
|---|---|
| Pages (from-to) | 165-175 |
| Number of pages | 11 |
| Journal | Magyar Onkologia |
| Volume | 60 |
| Issue number | 2 |
| Publication status | Published - jún. 6 2016 |
Fingerprint
ASJC Scopus subject areas
- Oncology
Cite this
Kemoterápia okozta szenzoros neuropátiák jellegzetességei, diagnosztikája és kezelése. / Istenes, Ildikó; Nagy, Zsolt; Demeter, J.
In: Magyar Onkologia, Vol. 60, No. 2, 06.06.2016, p. 165-175.Research output: Review article
}
TY - JOUR
T1 - Kemoterápia okozta szenzoros neuropátiák jellegzetességei, diagnosztikája és kezelése
AU - Istenes, Ildikó
AU - Nagy, Zsolt
AU - Demeter, J.
PY - 2016/6/6
Y1 - 2016/6/6
N2 - Longer remissions and better overall survival rates can be achieved with the introduction of new, effective treatments and targeted therapies in the past 1-2 decades, however, the incidence of side effects is also increasing parallelly. Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially debilitating side effect due to peripheral somatic or autonomic nerve dysfunction. CIPN becomes increasingly important, as it affects patients' quality of life, and it is very often a dose limiting factor with the potential for reduced treatment efficacy. The pathomechanism, diagnosis, prevention and treatment possibilities are described in this review with special attention to the different groups of drugs.
AB - Longer remissions and better overall survival rates can be achieved with the introduction of new, effective treatments and targeted therapies in the past 1-2 decades, however, the incidence of side effects is also increasing parallelly. Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially debilitating side effect due to peripheral somatic or autonomic nerve dysfunction. CIPN becomes increasingly important, as it affects patients' quality of life, and it is very often a dose limiting factor with the potential for reduced treatment efficacy. The pathomechanism, diagnosis, prevention and treatment possibilities are described in this review with special attention to the different groups of drugs.
UR - http://www.scopus.com/inward/record.url?scp=85046818915&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046818915&partnerID=8YFLogxK
M3 - Review article
VL - 60
SP - 165
EP - 175
JO - Magyar Onkologia
JF - Magyar Onkologia
SN - 0025-0244
IS - 2
ER -